Association of pharmacokinetics and pharmacogenomics with safety and efficacy of gefitinib in patients with EGFR mutation positive advanced non-small cell lung cancer

Lung Cancer ◽  
2016 ◽  
Vol 93 ◽  
pp. 69-76 ◽  
Author(s):  
Takashi Hirose ◽  
Ken-ichi Fujita ◽  
Sojiro Kusumoto ◽  
Yasunari Oki ◽  
Yasunori Murata ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Egfr Mutation ◽  
Small Cell ◽  
Small Cell Lung ◽  
Safety And Efficacy

Influence of dose adjustment on afatinib safety and efficacy in patients (pts) with advanced EGFR mutation-positive (EGFRm+) non-small cell lung cancer (NSCLC).

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. 8073-8073 ◽  
Author(s):  
James Chih-Hsin Yang ◽  
Myung-Ju Ahn ◽  
Nicolas J. Dickgreber ◽  
Balazs Halmos ◽  
Vera Hirsh ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Dose Adjustment ◽  
Egfr Mutation ◽  
Small Cell ◽  
Small Cell Lung ◽  
Safety And Efficacy
Sign in / Sign up

Export Citation Format

Share Document